Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Specialty Laboratories, Inc. was a leading clinical reference laboratory renowned for its expertise in esoteric testing, molecular diagnostics, and immunodiagnostics. Founded in 1975 to provide highly specialized and often complex laboratory services not routinely available, it played a significant role in advancing diagnostic capabilities for a wide range of medical conditions. Acquired by Quest Diagnostics in 1999, its legacy of innovation in specialized testing continues within Quest's broader network, contributing to improved patient care through precise and advanced diagnostic insights.
Served as the central hub for its nationwide esoteric testing operations, including advanced research, development, and complex sample processing.
State-of-the-art laboratory facilities equipped for a wide array of specialized diagnostic procedures, including molecular biology, immunology, genetics, and flow cytometry.
Characterized by a strong scientific focus, meticulous attention to detail, innovation in test development, and collaboration among highly specialized scientific and medical staff.
A key center for the development and provision of esoteric tests, significantly contributing to the fields of specialized diagnostics and the early movements towards personalized medicine.
Prior to its acquisition, Specialty Laboratories primarily served the U.S. market, though its unique and specialized tests likely attracted samples and collaborations from international healthcare providers and researchers on a case-by-case basis. As part of Quest Diagnostics, its capabilities are now integrated into a company with a significant global presence, supporting clinical trials, diagnostic services, and healthcare solutions worldwide.
25601 West Avenue Stanford
Valencia
California
USA
Address: Not publicly listed for historical minor offices
To provide localized client support, sales activities, and facilitate specimen collection/logistics across the United States.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Specialty Laboratories' leadership includes:
Specialty Laboratories has been backed by several prominent investors over the years, including:
As Specialty Laboratories was acquired by Quest Diagnostics in 1999 and no longer operates as an independent entity, there are no executive new hires or exits specific to 'Specialty Laboratories' in the last 12 months. Any relevant leadership changes would be within Quest Diagnostics' organizational structure.
Discover the tools Specialty Laboratories uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
The email formats for Specialty Laboratories (using the specialtylabs.com domain) are historical, as the company was acquired and its domain now redirects to Quest Diagnostics. Common corporate email formats at that time might have included first initial + last name or first name.last name.
[first_initial][last]@specialtylabs.com or [first].[last]@specialtylabs.com (historical, no longer active)
Format
jdoe@specialtylabs.com (example, historical, no longer active)
Example
0 (domain no longer active for original company emails)%
Success rate
The Free Library / PR Newswire • August 10, 1999
Quest Diagnostics Incorporated (NYSE: DGX) today announced it has completed its acquisition of Specialty Laboratories Inc. (NASDAQ: SPCL). Specialty Laboratories, based in Santa Monica, Calif., was a leading national provider of esoteric diagnostic testing services. The acquisition significantly enhanced Quest Diagnostics' capabilities in specialized testing and expanded its leadership in the diagnostic laboratory industry....more
Quest Diagnostics Newsroom • January 9, 2024
Quest Diagnostics announced the launch of a new test service using genotyping technology to identify individuals at risk of alpha-1 antitrypsin deficiency (AATD), a genetic condition that can lead to lung and liver disease. This development underscores Quest's ongoing commitment to providing advanced diagnostic tools for genetic and rare conditions, building upon a legacy of specialized testing services, including those historically developed by entities like Specialty Laboratories....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Specialty Laboratories, are just a search away.